Laboratory Testing in Telogen Effluvium
Telogen effluvium (TE) – a common cause of non- scarring hair loss – is managed with varying clinical protocols given the paucity of evidence-based practices.
INTRODUCTION
Telogen effluvium (TE) – a common cause of non-scarring hair loss – is managed with varying clinical protocols given the paucity of evidence-based practices. While endocrine, vitamin, and mineral abnormalities …
Telogen effluvium (TE) – a common cause of non- scarring hair loss – is managed with varying clinical protocols given the paucity of evidence-based practices.
INTRODUCTION
Telogen effluvium (TE) – a common cause of non-scarring hair loss – is managed with varying clinical protocols given the paucity of evidence-based practices. While endocrine, vitamin, and mineral abnormalities … 
The March 2022 issue of the Journal of Drugs in Dermatology (JDD) includes the perfect blend of original articles, case reports, and editorials. With topics ranging from acne and psoriasis to Platelet Rich Plasma (PRP) for scarring alopecia and racial differences and their impact on treatment for hidradenitis suppurativa, we share this month’s issue highlights straight from the JDD Editor’s de … 
Dermatologists should adopt gender-neutral language in interactions with aesthetic patients, according to “A Genderfluid Approach to Aesthetic Language in Dermatology” by Marc Beuttler, MD, and Jennifer MacGregor, MD, published in the Journal of Drugs in Dermatology in January 2022. Gender-neutral language helps dermatologists prevent psychological upset or offense for patients with nonbinary … 
The February 2022 issue of the Journal of Drugs in Dermatology (JDD) includes the perfect blend of original articles, case reports, and editorials. With topics ranging from psoriasis and actinic keratoses to artificial intelligence in dermatology and disparities in telemedicine satisfaction, we share this month’s issue highlights straight from the JDD Editor’s desk:
Early Response is Associ … 
The Journal of Drugs in Dermatology kicks off 2022 with an outstanding line up of editorials, original articles, and case reports focusing on aesthetic treatments. Straight from the Editor’s desk, we share this month’s issue highlights:
Authors establish that the test device is non-inferior to the comparator in Safety and Effectiveness of a Novel Hyaluronic Acid Gel for Lip Augmentation.
… 